ZimVie

$ZimVie(ZIMV)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-25-164864  Act: 34  Size: 32 KB 网页链接

$ZimVie(ZIMV)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001444043-25-000004  Act: 34  Size: 141 KB 网页链接

$ZimVie(ZIMV)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-25-161945  Act: 34  Size: 247 KB 网页链接

$ZimVie(ZIMV)$ PREM14A Preliminary proxy statements relating to merger or acquisition Accession Number: 0001193125-25-181940  Act: 34  Size: 2 MB 网页链接

$ZimVie(ZIMV)$ DEFM14A Definitive proxy statement relating to merger or acquisition Accession Number: 0001193125-25-194129  Act: 34  Size: 2 MB 网页链接

$ZimVie(ZIMV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001909313-25-000003  Size: 4 KB 网页链接

$ZimVie(ZIMV)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001654954-25-010077  Act: 34  Size: 55 KB 网页链接

$ZimVie(ZIMV)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001076809-25-000107  Act: 34  Size: 8 KB 网页链接

$ZimVie(ZIMV)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-25-233580  Act: 34  Size: 17 KB 网页链接

$ZimVie(ZIMV)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-25-161553  Act: 34  Size: 649 KB 网页链接

$ZimVie(ZIMV)$ SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership Accession Number: 0000807249-25-000097  Act: 34  Size: 37 KB 网页链接

$ZimVie(ZIMV)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-25-100255  Act: 34  Size: 9 MB 网页链接

$ZimVie(ZIMV)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-25-230320  Act: 34  Size: 59 KB 网页链接

$ZimVie(ZIMV)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001193125-25-161550  Act: 34  Size: 930 KB 网页链接

三年前ZimVie从捷迈邦美分拆上市，短短数年，便步入了众多MedTech企业熟悉的结局—被PE收购并退市。
7月21日，ZimVie宣布将被医疗PE Archimed以约7.3亿美元（约合人民币52亿）现金收购，报价较其90日平均股价溢价近一倍，并计划从纳斯达克退市。
消息发布后，ZimVie股价大涨约122%，从8.44...

$ZimVie(ZIMV)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-25-162546  Act: 34  Size: 248 KB 网页链接

$ZimVie(ZIMV)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-25-100232  Act: 34  Size: 1 MB 网页链接

$ZimVie(ZIMV)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-25-100253  Act: 34  Size: 1 MB 网页链接

$ZimVie(ZIMV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001341125-25-000005  Size: 5 KB 网页链接

$ZimVie(ZIMV)$ 8-K Current report, item 8.01 Accession Number: 0001193125-25-230313  Act: 34  Size: 193 KB 网页链接